Identification of HLA-A*02:01-restricted CTL epitopes in Trypanosoma cruzi heat shock protein-70 recognized by Chagas disease patients

Microbes and Infection

Volumn 13, Issue 12-13, 2011, Pages 1025-1032

  Marañón, Concepción ^a   Egui, Adriana ^a   Carrilero, Bartolomé ^b   Thomas, M Carmen ^a   Pinazo, M Jesús ^c   Gascón, Joaquim ^c   Segovia, Manuel ^b   López, Manuel Carlos ^a  

^a INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

CD8 antigen; Chagas disease; Cytotoxic T lymphocytes; Heat shock protein; Trypanosoma cruzi

Indexed keywords

ANTIBODY; EPITOPE; HEAT SHOCK PROTEIN 70; HLA A ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PEPTIDE; HLA A*02:01 ANTIGEN; HLA A2 ANTIGEN; HLA-A*02:01 ANTIGEN; MONOCLONAL ANTIBODY; PROTOZOAL PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BIOINFORMATICS; CD8+ T LYMPHOCYTE; CELL STRAIN K 562; CHAGAS DISEASE; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; FEMALE; HISTORY; HUMAN; HUMAN CELL; IMMUNIZATION; MICROBIAL IDENTIFICATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; TRANSGENIC MOUSE; TRYPANOSOMA CRUZI; ALGORITHM; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; GENETICS; IMMUNOLOGY; PARASITOLOGY;

MUS; PROTOZOA; TRYPANOSOMA CRUZI;

ADULT; ALGORITHMS; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CHAGAS DISEASE; EPITOPES, T-LYMPHOCYTE; FEMALE; HLA-A2 ANTIGEN; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNIZATION; IMMUNODOMINANT EPITOPES; K562 CELLS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PEPTIDES; PROTOZOAN PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TRYPANOSOMA CRUZI;

EID: 80053384534     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2011.05.010     Document Type: Article

References (48)

1. Rassi A., Rassi A., Marin-Neto J.A. Chagas disease. Lancet 2010, 375:1388-1402.
2. Bustamante J.M., Bixby L.M., Tarleton R.L. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 2008, 14:542-550.
3. Padilla A.M., Bustamante J.M., Tarleton R.L. CD8+ T cells in Trypanosoma cruzi infection. Curr. Opin. Immunol. 2009, 21:385-390.
4. Diez H., Lopez M.C., Del Carmen Thomas M., Guzman F., Rosas F., Velazco V., Gonzalez J.M., Puerta C. Evaluation of IFN-gamma production by CD8 T lymphocytes in response to the K1 peptide from KMP-11 protein in patients infected with Trypanosoma cruzi. Parasite Immunol. 2006, 28:101-105.
5. Martin D.L., Weatherly D.B., Laucella S.A., Cabinian M.A., Crim M.T., Sullivan S., Heiges M., Craven S.H., Rosenberg C.S., Collins M.H., Sette A., Postan M., Tarleton R.L. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2006, 2:e77.
6. Fonseca S.G., Moins-Teisserenc H., Clave E., Ianni B., Nunes V.L., Mady C., Iwai L.K., Sette A., Sidney J., Marin M.L., Goldberg A.C., Guilherme L., Charron D., Toubert A., Kalil J., Cunha-Neto E. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect. 2005, 7:688-697.
7. Garcia F., Sepulveda P., Liegeard P., Gregoire J., Hermann E., Lemonnier F., Langlade-Demoyen P., Hontebeyrie M., Lone Y.C. Identification of HLA-A*0201-restricted cytotoxic T-cell epitopes of Trypanosoma cruzi TcP2beta protein in HLA-transgenic mice and patients. Microbes Infect. 2003, 5:351-359.
8. Henderson B. Integrating the cell stress response: a new view of molecular chaperones as immunological and physiological homeostatic regulators. Cell Biochem. Funct. 2010, 28:1-14.
9. Tsan M.F., Gao B. Heat shock proteins and immune system. J. Leukoc. Biol. 2009, 85:905-910.
10. Bonorino C., Nardi N.B., Zhang X., Wysocki L.J. Characteristics of the strong antibody response to mycobacterial Hsp70: a primary, T cell-dependent IgG response with no evidence of natural priming or gamma delta T cell involvement. J. Immunol. 1998, 161:5210-5216.
11. Greiner J., Ringhoffer M., Taniguchi M., Hauser T., Schmitt A., Dohner H., Schmitt M. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int. J. Cancer 2003, 106:224-231.
12. Carralot J.P., Dumrese C., Wessel R., Riessen R., Autenrieth I., Walter S., Schoor O., Stevanovic S., Rammensee H.G., Pascolo S. CD8+ T cells specific for a potential HLA-A*0201 epitope from Chlamydophila pneumoniae are present in the PBMCs from infected patients. Int. Immunol. 2005, 17:591-597.
13. Faure O., Graff-Dubois S., Bretaudeau L., Derre L., Gross D.A., Alves P.M., Cornet S., Duffour M.T., Chouaib S., Miconnet I., Gregoire M., Jotereau F., Lemonnier F.A., Abastado J.P., Kosmatopoulos K. Inducible Hsp70 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes. Int. J. Cancer 2004, 108:863-870.
14. Maranon C., Planelles L., Alonso C., Lopez M.C. HSP70 from Trypanosoma cruzi is endowed with specific cell proliferation potential leading to apoptosis. Int. Immunol. 2000, 12:1685-1693.
15. Qazi K.R., Oehlmann W., Singh M., Lopez M.C., Fernandez C. Microbial heat shock protein 70 stimulatory properties have different TLR requirements. Vaccine 2007, 25:1096-1103.
16. Maranon C., Thomas M.C., Planelles L., Lopez M.C. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes. Mol. Immunol. 2001, 38:279-287.
17. Planelles L., Thomas M.C., Alonso C., Lopez M.C. DNA immunization with Trypanosoma cruzi HSP70 fused to the KMP11 protein elicits a cytotoxic and humoral immune response against the antigen and leads to protection. Infect. Immun. 2001, 69:6558-6563.
18. Requena J.M., Soto M., Guzman F., Maekelt A., Noya O., Patarroyo M.E., Alonso C. Mapping of antigenic determinants of the T. cruzi hsp70 in chagasic and healthy individuals. Mol. Immunol. 1993, 30:1115-1121.
19. Krautz G.M., Peterson J.D., Godsel L.M., Krettli A.U., Engman D.M. Human antibody responses to Trypanosoma cruzi 70-kD heat-shock proteins. Am. J. Trop. Med. Hyg. 1998, 58:137-143.
20. Flechas I.D., Cuellar A., Cucunuba Z.M., Rosas F., Velasco V., Steindel M., Thomas Mdel C., Lopez M.C., Gonzalez J.M., Puerta C.J. Characterising the KMP-11 and HSP-70 recombinant antigens' humoral immune response profile in chagasic patients. BMC Infect. Dis. 2009, 9:186.
21. Vitiello A., Marchesini D., Furze J., Sherman L.A., Chesnut R.W. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J. Exp. Med. 1991, 173:1007-1015.
22. Britten C.M., Meyer R.G., Kreer T., Drexler I., Wolfel T., Herr W. The use of HLA-A*0201-transfected K562 as standard antigen-presenting cells for CD8(+) T lymphocytes in IFN-gamma ELISPOT assays. J. Immunol. Methods 2002, 259:95-110.
23. Zweerink H.J., Gammon M.C., Utz U., Sauma S.Y., Harrer T., Hawkins J.C., Johnson R.P., Sirotina A., Hermes J.D., Walker B.D., Biddison W.E. Presentation of endogenous peptides to MHC class I-restricted cytotoxic T lymphocytes in transport deletion mutant T2 cells. J. Immunol. 1993, 150:1763-1771.
24. Rammensee H., Bachmann J., Emmerich N.P., Bachor O.A., Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 1999, 50:213-219.
25. Reche P.A., Glutting J.P., Zhang H., Reinherz E.L. Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics 2004, 56:405-419.
26. Gotch F., Rothbard J., Howland K., Townsend A., McMichael A. Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2. Nature 1987, 326:881-882.
27. Pogue R.R., Eron J., Frelinger J.A., Matsui M. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc. Natl. Acad. Sci. U S A 1995, 92:8166-8170.
28. Hoeffel G., Ripoche A.C., Matheoud D., Nascimbeni M., Escriou N., Lebon P., Heshmati F., Guillet J.G., Gannage M., Caillat-Zucman S., Casartelli N., Schwartz O., De la Salle H., Hanau D., Hosmalin A., Maranon C. Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 2007, 27:481-492.
29. Keogh E., Fikes J., Southwood S., Celis E., Chesnut R., Sette A. Identification of new epitopes from four different tumor-associated antigens: recognition of naturally processed epitopes correlates with HLA-A*0201-binding affinity. J. Immunol. 2001, 167:787-796.
30. Gaudin C., Kremer F., Angevin E., Scott V., Triebel F. A hsp70-2 mutation recognized by CTL on a human renal cell carcinoma. J. Immunol. 1999, 162:1730-1738.
31. Wentworth P.A., Vitiello A., Sidney J., Keogh E., Chesnut R.W., Grey H., Sette A. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 1996, 26:97-101.
32. Rosenberg C.S., Martin D.L., Tarleton R.L. CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of Trypanosoma cruzi infection but are not required for resistance. J. Immunol. 2010, 185:560-568.
33. Gowthaman U., Chodisetti S.B., Parihar P., Agrewala J.N. Evaluation of different generic in silico methods for predicting HLA class I binding peptide vaccine candidates using a reverse approach. Amino Acids 2010, 39:1333-1342.
34. Morell M., Thomas M.C., Caballero T., Alonso C., Lopez M.C. The genetic immunization with paraflagellar rod protein-2 fused to the HSP70 confers protection against late Trypanosoma cruzi infection. Vaccine 2006, 24:7046-7055.
35. Guevara-Patino J.A., Engelhorn M.E., Turk M.J., Liu C., Duan F., Rizzuto G., Cohen A.D., Merghoub T., Wolchok J.D., Houghton A.N. Optimization of a self antigen for presentation of multiple epitopes in cancer immunity. J. Clin. Invest. 2006, 116:1382-1390.
36. Kotturi M.F., Botten J., Sidney J., Bui H.H., Giancola L., Maybeno M., Babin J., Oseroff C., Pasquetto V., Greenbaum J.A., Peters B., Ting J., Do D., Vang L., Alexander J., Grey H., Buchmeier M.J., Sette A. A multivalent and cross-protective vaccine strategy against arenaviruses associated with human disease. PLoS Pathog. 2009, 5:e1000695.
37. Guo Y.J., Wang K.Y., Sun S.H. Identification of an HLA-A*0201-restricted CD8(+) T-cell epitope encoded within Leptospiral immunoglobulin-like protein A. Microbes Infect. 2010, 12:364-373.
38. Garg N., Nunes M.P., Tarleton R.L. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol. 1997, 158:3293-3302.
39. Lund P.A. Microbial molecular chaperones. Adv. Microb. Physiol. 2001, 44:93-140.
40. Calderwood S.K., Mambula S.S., Gray P.J., Theriault J.R. Extracellular heat shock proteins in cell signaling. FEBS Lett. 2007, 581:3689-3694.
41. Cuervo P., De Jesus J.B., Saboia-Vahia L., Mendonca-Lima L., Domont G.B., Cupolillo E. Proteomic characterization of the released/secreted proteins of Leishmania (Viannia) braziliensis promastigotes. J. Proteomics 2009, 73:79-92.
42. Giambiagi-deMarval M., Souto-Padron T., Rondinelli E. Characterization and cellular distribution of heat-shock proteins HSP70 and HSP60 in Trypanosoma cruzi. Exp. Parasitol. 1996, 83:335-345.
43. Muller U., Sobek V., Balkow S., Holscher C., Mullbacher A., Museteanu C., Mossmann H., Simon M.M. Concerted action of perforin and granzymes is critical for the elimination of Trypanosoma cruzi from mouse tissues, but prevention of early host death is in addition dependent on the FasL/Fas pathway. Eur. J. Immunol. 2003, 33:70-78.
44. Laucella S.A., Postan M., Martin D., Hubby Fralish B., Albareda M.C., Alvarez M.G., Lococo B., Barbieri G., Viotti R.J., Tarleton R.L. Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 2004, 189:909-918.
45. Alvarez M.G., Postan M., Weatherly D.B., Albareda M.C., Sidney J., Sette A., Olivera C., Armenti A.H., Tarleton R.L., Laucella S.A. HLA class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8 T cells in chronic Chagas disease. PLoS Negl. Trop. Dis. 2008, 2:e288.
46. Krausa P., Brywka M., Savage D., Hui K.M., Bunce M., Ngai J.L., Teo D.L., Ong Y.W., Barouch D., Allsop C.E., Hill A.V.S., McMichael A.J., Bodmer J.G., Browning M.J. Genetic polymorphism within HLA-A*02: significant allelic variation revealed in different populations. Tissue Antigens 1995, 45:223-231.
47. Choppin J., Cohen W., Bianco A., Briand J.P., Connan F., Dalod M., Guillet J.G. Characteristics of HIV-1 Nef regions containing multiple CD8+ T cell epitopes: wealth of HLA-binding motifs and sensitivity to proteasome degradation. J. Immunol. 2001, 166:6164-6169.
48. Lasso P., Mesa D., Cuellar A., Guzman F., Bolanos N., Rosas F., Velasco V., Thomas Mdel C., Lopez M.C., Gonzalez J.M., Puerta C.J. Frequency of specific CD8+ T cells for a promiscuous epitope derived from Trypanosoma cruzi KMP-11 protein in chagasic patients. Parasite Immunol. 2010, 32:494-502.